drugset
drugset / Trial / NCT02635750

Investigation of Pharmacokinetic Drug-drug Interaction of BI 409306 and Donepezil in Healthy Male and Female Subjects

NCT02635750 ↗

Phase 1 Completed 32 enrolled Boehringer Ingelheim
RandomizedCrossoverOpen-labelTreatment

Summary

Part I: To investigate whether and to what extent donepezil affects single dose pharmacokinetics of BI 409306 Part II: To investigate whether and to what extent BI 409306 affects the single dose pharmacokinetics of donepezil

Timeline

Start
2016-01-15
Primary completion
2016-03-16
Completion
2016-04-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Donepezil Small molecule 5 mg Oral
Subject Donepezil Small molecule 10 mg Oral
Subject OSORESNONTRINE Small molecule 25 mg Oral
Subject OSORESNONTRINE Small molecule 100 mg Oral

Indications

No indication recorded.